Cargando…
Nutrients and probiotics: current trends in their use to eradicate Helicobacter pylori
Helicobacter pylori is a well-known bacterium that infects the human gastric mucosa and causes gastric inflammation, ultimately resulting in gastric cancer. To reduce the incidence of gastric cancer, eradication therapy is important. However, the rate of successful eradication gradually decreases du...
Autores principales: | Handa, Osamu, Naito, Yuji, Osawa, Motoyasu, Murao, Takahisa, Matsumoto, Hiroshi, Umegaki, Eiji, Shiotani, Akiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
the Society for Free Radical Research Japan
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417805/ https://www.ncbi.nlm.nih.gov/pubmed/32801465 http://dx.doi.org/10.3164/jcbn.20-51 |
Ejemplares similares
-
P2Y12 Inhibitors Exacerbate Low-dose Aspirin-induced Small Bowel Injury in Dual Antiplatelet Therapy
por: Handa, Yukiko, et al.
Publicado: (2021) -
Comparison of mucosa-associated microbiota in Crohn’s disease patients with and without anti-tumor necrosis factor-α therapy
por: Fukushima, Shinya, et al.
Publicado: (2022) -
Effectiveness of including probiotics to Helicobacter pylori eradication therapies
por: Mukai, Rieko, et al.
Publicado: (2020) -
Reduced abundance of butyric acid-producing bacteria in the ileal mucosa-associated microbiota of ulcerative colitis patients
por: Osawa, Motoyasu, et al.
Publicado: (2023) -
Reduction of butyric acid-producing bacteria in the ileal mucosa-associated microbiota is associated with the history of abdominal surgery in patients with Crohn’s disease
por: Handa, Osamu, et al.
Publicado: (2023)